Automated ankle-brachial pressure index measurement by clinical staff for PAD diagnosis in non-diabetic and diabetic patients
- Cécile CLAIROTTE, MD1,
- Sylvie RETOUT, PhD2,4,7,
- Louis POTIER, MD2,
- Ronan ROUSSEL, MD, PhD3,4,6 and
- Brigitte ESCOUBET, MD, PhD (brigitte.escoubet{at}inserm.fr)1,4,5
- 1 Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Département de Physiologie, Explorations Fonctionnelles, Paris, France
- 2 Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Unité Fonctionnelle de, Biostatistiques, Paris, France
- 3 Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Département d'Endocrinologie, Diabétologie et Nutrition, Paris, France
- 4 Université Paris – Diderot, Paris 7, UFR Médicale, Paris, France
- 5 Inserm, U872, Paris, France
- 6 Inserm, U695, Paris, France
- 7 Inserm, U738, Paris, France
Abstract
Objective: Peripheral arterial disease (PAD) is a prognostic marker in cardiovascular disease. The use of Doppler ankle brachial pressure index (Dop-ABI) for PAD diagnosis is limited because of time, require training and costs. We assessed automated measurement of ABI (Osc-ABI) by nurses and clinical staff.
Research Design and Methods: Clinical staff measured Osc-ABI with an automated oscillometric device in 146 patients (83 with diabetes) at the time of Dop-ABI measurement and ultrasound evaluation.
Results: ABI was obtained in most legs (Dop-ABI: 98% Osc-ABI: 95.5%). Dop- and Osc-ABI were significantly related in diabetic and non-diabetic patients with good agreement over a wide range of values. When Dop-ABI ≤0.90 was used as the gold standard for PAD, Receiver-Operating Characteristic Curve analysis showed that PAD was accurately diagnosed with Osc-ABI in diabetic patients. When ultrasound-defined PAD, Dop-ABI had better diagnostic performance than Osc-ABI in the whole population, and in diabetic patients (p=0.026). Both methods gave similar results in non-diabetic patients. The cut-off values for the highest sensitivity and specificity for PAD screening were 1.0 to 1.1, respectively. Estimation of cost with the French medical care system fees showed a potential reduction by 3 of the screening procedure.
Conclusions: PAD screening could be improved by using Osc-ABI measured by clinical staff with the benefit of a greater cost-effectiveness, but at the expense of lower diagnostic performance in diabetic patients.
Footnotes
-
- Received December 15, 2008.
- Accepted March 21, 2009.
- Copyright © American Diabetes Association














